Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 19.91B | 20.62B | 19.83B | 18.33B | 16.68B | 17.21B |
Gross Profit | -32.40B | 20.62B | 20.63B | 18.33B | 16.68B | 17.21B |
EBITDA | -363.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 6.96B | 6.96B | 7.41B | 6.89B | 6.36B | 3.50B |
Balance Sheet | ||||||
Total Assets | 1.08T | 1.08T | 1.06T | 1.06T | 925.97B | 866.57B |
Cash, Cash Equivalents and Short-Term Investments | 112.94B | 112.94B | 120.20B | 144.53B | 109.21B | 160.95B |
Total Debt | 296.68B | 296.68B | 196.31B | 190.26B | 169.84B | 132.57B |
Total Liabilities | 1.02T | 1.02T | 997.58B | 996.09B | 863.19B | 805.27B |
Stockholders Equity | 61.45B | 61.45B | 61.15B | 59.03B | 62.78B | 61.29B |
Cash Flow | ||||||
Free Cash Flow | -68.91B | -37.22B | -27.89B | 27.14B | -99.00M | 32.92B |
Operating Cash Flow | -67.47B | -35.78B | -26.70B | 28.22B | 759.00M | 33.89B |
Investing Cash Flow | 4.69B | 4.69B | -4.21B | -8.70B | -3.69B | -702.00M |
Financing Cash Flow | 41.60B | 9.92B | 6.98B | 6.01B | -22.05B | -16.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $56.10B | 8.90 | 13.80% | 4.69% | 10.03% | 29.51% | |
78 Outperform | $69.86B | 9.04 | 9.83% | 2.20% | 16.06% | 64.31% | |
77 Outperform | $262.14B | 13.81 | 11.51% | 2.09% | 0.37% | 19.89% | |
75 Outperform | $106.08B | 9.13 | 18.32% | 4.28% | 7.86% | 17.13% | |
75 Outperform | $72.69B | 11.10 | 12.08% | 4.79% | 1.13% | -1.14% | |
68 Neutral | $18.06B | 11.97 | 10.24% | 3.74% | 9.75% | 1.30% | |
66 Neutral | $85.70B | 19.11 | 11.51% | 3.86% | 6.07% | -0.29% |